Amdocs Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Benzinga
2025/11/11

Amdocs Limited (NASDAQ:DOX) will release earnings results for its fourth quarter, after the closing bell on Tuesday, Nov. 11.

Analysts expect the Saint Louis, Missouri-based company to report quarterly earnings at $1.82 per share, up from $1.70 per share in the year-ago period. The consensus estimate for Amdocs' quarterly revenue is $1.15 billion, compared to $1.26 billion a year earlier, according to data from Benzinga Pro.

On Sept. 10, Amdocs signed a multi‑year agreement to extend and deepen managed transformation initiative using Amdocs’ AI offerings.

Amdocs shares rose 1.1% to close at $85.49 on Monday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.

  • Wolfe Research analyst George Notter initiated coverage on the stock with an Outperform rating on July 8, 2025. This analyst has an accuracy rate of 75%.
  • Oppenheimer analyst Timothy Horan maintained an Outperform rating and raised the price target from $98 to $105 on Nov. 13, 2025. This analyst has an accuracy rate of 71%.
  • Stifel analyst Shlomo Rosenbaum initiated coverage on the stock with a Buy rating and a price target of $100 on Oct. 2, 2025. This analyst has an accuracy rate of 65%.
  • Citigroup analyst Ashwin Shirvaikar maintained a Buy rating and cut the price target from $105 to $100 on May 9, 2025. This analyst has an accuracy rate of 71%.
  • Baird analyst William Power maintained a Neutral rating and slashed the price target from $97 to $90 on May 9, 2025. This analyst has an accuracy rate of 84%.

Considering buying DOX stock? Here’s what analysts think:

Read This Next:

  • Top 2 Utilities Stocks That May Crash This Quarter

Photo via Shhutterstock

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10